Kalvista Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Kalvista Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Kalvista Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Kalvista Pharmaceuticals by MetLife Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $258k | 22k | 11.58 |
2024-06-30 | $263k | 22k | 11.78 |
2023-12-31 | $206k | 17k | 12.25 |
2023-09-30 | $120k | 13k | 9.63 |
2023-06-30 | $113k | 13k | 9.00 |
2023-03-31 | $98k | 13k | 7.86 |
2022-12-31 | $85k | 13k | 6.76 |
2022-09-30 | $181k | 13k | 14.51 |
2022-06-30 | $123k | 13k | 9.84 |
2022-03-31 | $184k | 13k | 14.74 |
2021-12-31 | $81k | 6.1k | 13.23 |
2021-09-30 | $107k | 6.1k | 17.46 |
2021-06-30 | $147k | 6.1k | 23.98 |
2021-03-31 | $157k | 6.1k | 25.61 |
2020-12-31 | $135k | 7.1k | 18.99 |
2019-06-30 | $139k | 6.3k | 22.15 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors